KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1

Historical Portfolio Holders from Q4 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 3.000%10/1
Principal, excl. options Q1 2024
151 M
Holdings value Q1 2024
$93.9 M
Value change Q1 2024
-$11.7 B
Grand Portfolio weight change Q1 2024
-0.024%
Number of holders
11
Number of buys Q1 2024
0
Number of sells Q1 2024
0
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0
CUSIP
48576UAA4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $151 M $93.9 M -$11.7 B $0.54 11
2023 Q4 $170 M $86 M +$11.4 M $0.50 11
2023 Q3 $140 M $103 M $0 $0.63 10
2023 Q2 $140 M $108 M +$1.4 M $0.68 10
2023 Q1 $167 M $143 M +$336 K $0.77 10
2022 Q4 $157 M $129 M -$510 K $0.76 9
2022 Q3 $91.4 M $83.8 M -$1.74 M $0.81 8
2022 Q2 $101 M $78.8 M -$56.1 M $0.73 10
2022 Q1 $162 M $148 M +$398 K $0.84 18
2021 Q4 $151 M $136 M -$1.12 M $0.82 18
2021 Q3 $164 M $134 M -$7.15 M $0.75 17
2021 Q2 $164 M $179 M +$5.06 M $1.00 17
2021 Q1 $162 M $179 M -$13.6 M $1.04 13
2020 Q4 $179 M $224 M +$2.42 M $1.26 13
2020 Q3 $177 M $213 M -$7.31 M $1.20 13
2020 Q2 $180 M $254 M +$147 K $1.40 16
2020 Q1 $179 M $258 M -$1.67 M $1.44 14
2019 Q4 $180 M $258 M +$258 M $1.43 17